Alert Context

Health systems are reporting persistent allocation constraints across nasal and oral/nasal endotracheal tubes, with the most acute pressure concentrated in pediatric and small adult sizes.

Cato's sourcing intelligence indicates this is a quality-driven supply contraction compounded by the structural architecture of a highly concentrated market.

Supply Gap Analysis

The current supply gap reflects several converging upstream pressures rather than a single cause.

Over the past year, the nasal and oral/nasal ETT category has been impacted by multiple quality-driven contractions. At least two major manufacturers have issued significant recalls or market withdrawals affecting tube sizes in pediatric and small adult ranges.

In one case, the contraction was driven by a manufacturing variance that forced immediate quarantine or destruction of on-hand inventory. In another, documented device failure reports resulted in a full product line exit.

Both events removed meaningful inventory from a market with few substitutes for the affected sizes, and the cascade extended downstream into bundled convenience kits, further compounding the shortage at the facility level.

The structural problem is that ETT manufacturing is highly consolidated. When primary suppliers contract supply simultaneously, remaining manufacturers lack the surge capacity to absorb displaced volume, and the gap persists longer than it otherwise would.

Layered on top of this, tariff-driven cost increases on imported medical-grade PVC and silicone resins, the core inputs for tube extrusion, are narrowing manufacturers' economic incentive to redirect production capacity upward to fill the gap.

What Health Systems Can Do Now

Facilities can take proactive actions to reduce exposure.

1. Pre-approve substitutes before a stockout: Engage value analysis now, while there is still time to evaluate deliberately. This gives procurement the flexibility to act quickly when allocation windows open.
2. Validate securement compatibility: Tube holders and securing devices are often brand-matched by clinical habit. Confirm that OR and ICU securement inventory is compatible with substitute brands.

If a health system is encountering challenges with these SKUs, Cato is actively sourcing Medtronic Shiley and Mallinckrodt nasal and oral/nasal tracheal tubes, including Hi-Lo and RAE configurations, in cuffed and intermediate-cuff sizes.

If cases are at risk, send the sizes and case volumes, and Cato will run a real-time availability check.

Our Risk Radar tool provides a real-time panoramic view of supply fluctuations and affected categories.

‍

• Pre-approve substitute nasal and oral/nasal ETT options before allocation pressure becomes a stockout.
• Confirm securement compatibility across OR and ICU workflows before switching brands.
• Track pediatric and small adult sizes closely because the shortage pressure is most acute there.